Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19334078 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Pilot Clinical Trial of Sympathetic Blockade With Botulinum Toxin Type A to Treat Complex Regional Pain Syndrome (CRPS): a Randomized, Double-Blind, Controlled, Crossover Trial.
Condition: Pain
Intervention: Procedure: Lumbar sympathetic block with Botulinum Toxin type A

Indicates status has not been verified in more than two years